Effective process development for viral vector-based medicines is paramount for optimized process efficiency, robustness, scalability, and product quality. Well-designed processes streamline ...

Avid Bioservices has expanded its viral vector development and manufacturing facility with the addition of analytical and process development suites. Avid Bioservices, a biologics-focused contract ...

2 in-depth workshops to give you hands-on experience within 6 hrs 2 tracks dedicated to process development and manufacturing, bridging the gaps of PD and CMC and Tech Transfer Exclusive Data-Driven ...

Plasmids are essential for the development of viral vectors used to manufacture novel gene therapies and viral vaccines. Aldevron is supporting the innovation of drug developers in this space by ...

Over the evaluation period from 2023 to 2033, the global viral vector development market is predicted to grow at a remarkable CAGR of 18.7%. By the end of 2023, the global market is anticipated to be ...

CAMBRIDGE, Mass. & COLUMBUS, Ohio--(BUSINESS WIRE)--Solid Biosciences Inc. (Solid, Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy ...

In 2023, industry is witnessing a renaissance in viral vector characterization. Spurred by widespread biopharma investment to engineer a new wave of novel capsids and faced with newly launched QbD ...